Table 5.
Measure | High responders (n = 20) | Low responders (n = 6) | t(25) |
---|---|---|---|
Gender (girls:boys) | 5:15 | 1:5 | χ2 = 0.67, ns |
Age (months) | 41.67 (7.81) | 44.25 (7.32) | 0.75 |
External treatment (h) | 0.70 (0.98) | 0.83 (0.75) | 0.31 |
Previous exposure to MDI (%) | 41.2% | 37.5% | χ2 = 0.90, ns |
ADOS CSS | 6.50 (1.28) | 9.17 (1.28) | 4.69*** |
MSEL total DQ | 59.69 (16.20) | 34.82 (13.71) | 3.4** |
MSEL VR DQ | 62.85 (16.04) | 38.72 (18.62) | 3.12* |
MSEL FM DQ | 60.12 (13.69) | 43.33 (13.57) | 2.64* |
MSEL RL DQ | 60.01 (28.94) | 28.94 (16.90) | 3.14** |
MSEL EL DQ | 54.40 (21.80) | 28.29 (16.91) | 2.68* |
VABS-II-P composite | 72.94 (6.881) | 61.17 (6.55) | 3.70** |
VABS-II-T composite | 72.95 (15.15) | 56.00 (14.95) | 2.31* |
MDI: multidisciplinary developmental intervention; ADOS-CSS: autism diagnostic observation schedule calibrated severity score; MSEL: Mullen’s scales of early learning; DQ: developmental quotient; VR: visual reception; FM: fine motor; RL: receptive language; EL: expressive language; VABS-II-P: Vineland adaptive behavior scales, second edition, parent report; VABS-II-T: Vineland adaptive behavior scales, second edition, teacher report.
p < .05; **p < .01; ***p < .001